Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02404493 · ClinicalTrials.gov registry record · NA
Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy Skin
A NA study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02404493 is a NA study that was terminated before completion, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 23 participants.
The verdict
NCT02404493, a NA study, was terminated before completion, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this 3 week study is to test the effectiveness of an over-the-counter (OTC) skin balm in infants and toddlers with mild to moderate dry, itchy skin.
Interventions
- DEVICE EpiCeram Skin Barrier Emulsion
- DRUG 1% Colloidal Oatmeal Balm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02404493
The ClinicalTrials.gov registry entry for NCT02404493 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EpiCeram Skin Barrier Emulsion is the first listed.
NCT02404493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02404493 about?
NCT02404493 is a clinical study titled "Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy Skin". The purpose of this 3 week study is to test the effectiveness of an over-the-counter (OTC) skin balm in infants and toddlers with mild to moderate dry, itchy skin.
What is the current status of trial NCT02404493?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2015-03. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02404493?
The interventions under investigation include: EpiCeram Skin Barrier Emulsion (DEVICE), 1% Colloidal Oatmeal Balm (DRUG).
Who is sponsoring clinical trial NCT02404493?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.